Prevest Denpro

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0GAO01018
  • NSEID:
  • BSEID: 543363
INR
438.05
-11.95 (-2.66%)
BSENSE

Dec 05

BSE+NSE Vol: 800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003535,
    "name": "Prevest Denpro",
    "stock_name": "Prevest Denpro",
    "full_name": "Prevest Denpro Ltd",
    "name_url": "stocks-analysis/prevest-denpro",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "438.05",
    "chg": -11.95,
    "chgp": "-2.66%",
    "dir": -1,
    "prev_price": "450.00",
    "mcapval": "525.79 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543363,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE0GAO01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 800,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prevest-denpro-1003535-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Prevest Denpro overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prevest-denpro-overvalued-or-undervalued-3745670",
        "imagepath": "",
        "date": "2025-12-04 08:45:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and Financial Health</strong></p>\n<p>Prevest Denpro’s price-to-earnings (PE) ratio stands at approximately 27.3, which is elevated compared to many industry peers but not excessively high for a growth-oriented healthcare company. The price-to-book (P/B) ratio of 4.63 indicates that investors are paying a significant premium over the company’s net asset value, reflecting expectations of strong future earnings growth.</p>\n<p>Enterprise value to EBITDA (EV/EBITDA) at 19.4 and EV to EBIT at 21.2 further suggest that the market values the company’s operating profits highly. These multiples are lower than some very expensive peers but still indicate a premium valuation.</p>\n<p>Importantly, Prevest Denpro’s return on capital employed (ROCE) is an impressive 52.16%, signalling high..."
      },
      {
        "title": "Prevest Denpro Sees Revision in Market Evaluation Amidst Challenging Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prevest-denpro-downgraded-to-sell-by-marketsmojo-amidst-weak-financial-and-technical-signals-3738094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrevestDenpro_mojoScore_3738094.png",
        "date": "2025-12-01 10:09:16",
        "description": "Prevest Denpro, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. The company’s assessment metrics have been adjusted following a period marked by subdued financial trends and valuation concerns, signalling a cautious stance among investors."
      },
      {
        "title": "Why is Prevest Denpro falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prevest-denpro-fallingrising-3727148",
        "imagepath": "",
        "date": "2025-11-25 01:44:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Prevest Denpro’s stock has been on a downward spiral, losing 8.48% over the past week compared to a near-flat Sensex performance of -0.06%. The one-month decline is even more pronounced at -18.68%, while the Sensex has gained 0.82% in the same period. Year-to-date, the stock has fallen 27.14%, starkly contrasting with the Sensex’s 8.65% rise. Over the last year, Prevest Denpro has delivered a negative return of 20.39%, whereas the benchmark index has appreciated by 7.31%. Even over a three-year horizon, the stock’s 9.85% gain pales in comparison to the Sensex’s robust 36.34% advance.</p>\n<p>On 24-Nov, the stock opened with a gap down of 2.21% and continued to weaken, hitting an intraday low of ₹429.90, marking a 6.58% drop on the day. ..."
      },
      {
        "title": "Why is Prevest Denpro falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prevest-denpro-fallingrising-3716569",
        "imagepath": "",
        "date": "2025-11-20 00:07:05",
        "description": "As of 19-Nov, Prevest Denpro Ltd's stock price is currently at 465.00, reflecting a decrease of 3.95, or 0.84%. The stock has been underperforming, having lost 5.25% over the past week and 10.40% over the past month. It has also experienced a consecutive decline for the last five days. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a slight increase in delivery volume by 13.3% against the 5-day average, the overall performance today has underperformed the sector by 0.74%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Prevest Denpro's performance has significantly lagged behind the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, the stock has declined by 21.19%..."
      },
      {
        "title": "Prevest Denpro Q2 FY26: Strong Quarter Overshadowed by Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/prevest-denpro-q2-fy26-strong-quarter-overshadowed-by-valuation-concerns-3715489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrevestDenpro_quaterlyResult_3715489.png",
        "date": "2025-11-14 09:44:16",
        "description": "Prevest Denpro Limited, one of India's leading dental materials manufacturers, reported a robust second quarter for FY2026, with net profit climbing 25.62% quarter-on-quarter to ₹5.54 crores. However, the micro-cap company's stock has tumbled 11.31% over the past year, trading at ₹478.90 as of November 14, 2025, with a market capitalisation of ₹574.82 crores. Despite solid operational performance and industry-leading profitability metrics, the stock faces mounting pressure from stretched valuations and deteriorating technical momentum."
      },
      {
        "title": "How has been the historical performance of Prevest Denpro?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-prevest-denpro-3699730",
        "imagepath": "",
        "date": "2025-11-13 23:48:12",
        "description": "Answer:\nThe historical performance of Prevest Denpro shows a positive trend in key financial metrics from March 2024 to March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Prevest Denpro reported net sales of 63.03 Cr, an increase from 56.43 Cr in the previous year. The total operating income also rose to 63.03 Cr from 56.43 Cr, with raw material costs slightly increasing to 14.08 Cr from 13.76 Cr. Total expenditure, excluding depreciation, grew to 40.94 Cr from 36.58 Cr, leading to an operating profit (PBDIT) of 26.16 Cr, up from 22.71 Cr. Profit before tax increased to 24.25 Cr from 21.43 Cr, resulting in a profit after tax of 18.16 Cr, compared to 16.14 Cr the previous year. The earnings per share improved to 15.13 from 13.45, while the operating profit margin slightly decreased to 35.05% from 35.18%. The profit after tax margin increased to 28.81% from 28.6%. On the balance sheet, shareholder'..."
      },
      {
        "title": "How has been the historical performance of Prevest Denpro?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-prevest-denpro-3695702",
        "imagepath": "",
        "date": "2025-11-13 00:36:07",
        "description": "Answer:\nThe historical performance of Prevest Denpro shows significant growth from March 2024 to March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Prevest Denpro reported net sales of 63.03 Cr, an increase from 56.43 Cr in the previous year. Total operating income also rose to 63.03 Cr from 56.43 Cr, while total expenditure increased to 40.94 Cr from 36.58 Cr. The operating profit (PBDIT) excluding other income improved to 22.09 Cr compared to 19.85 Cr, leading to an overall operating profit of 26.16 Cr, up from 22.71 Cr. Profit before tax increased to 24.25 Cr from 21.43 Cr, resulting in a profit after tax of 18.16 Cr, which is higher than the 16.14 Cr reported in the prior year. The earnings per share also grew from 13.45 to 15.13. On the balance sheet, shareholder's funds rose to 105.57 Cr from 88.62 Cr, and total assets increased to 112.53 Cr from 94.82 Cr. The company maintained zero long-t..."
      },
      {
        "title": "Why is Prevest Denpro falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prevest-denpro-fallingrising-3687386",
        "imagepath": "",
        "date": "2025-11-11 00:02:43",
        "description": "As of 10-Nov, Prevest Denpro Ltd's stock price is currently at Rs 490.00, reflecting a decline of Rs 20.0 or 3.92%. The stock has been underperforming, having lost 6.66% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of returns, the stock has decreased by 5.77% over the past week and 9.01% over the past month, while it has experienced a significant drop of 16.95% year-to-date. Despite a low debt-to-equity ratio, the company has shown poor long-term growth, with net sales growing at an annual rate of only 13.42% and operating profit at 4.86% over the last five years. Additionally, the stock's valuation appears expensive with a price-to-book value of 5.6, and domestic mutual funds hold no stake in the company, indicating a lack of confidence in its current price.\n\nIn the broader market context, the Sensex has shown a relatively stable pe..."
      },
      {
        "title": "Is Prevest Denpro technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prevest-denpro-technically-bullish-or-bearish-3684134",
        "imagepath": "",
        "date": "2025-11-10 08:12:01",
        "description": "As of 7 November 2025, the technical trend has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD and Dow Theory indicators, both indicating a bearish outlook. The Bollinger Bands also reflect a bearish sentiment on both weekly and monthly time frames. Although the daily moving averages show a mildly bullish signal, this is overshadowed by the overall bearish indicators. The stock has underperformed against the Sensex over multiple periods, further supporting the bearish view...."
      }
    ],
    "total": 172,
    "sid": "1003535",
    "stock_news_url": "https://www.marketsmojo.com/news/prevest-denpro-1003535"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "24-Nov-2025",
      "details": "Transcipt of the Companys Earning call held on November 20 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "21-Nov-2025",
      "details": "Please find enclosed the audio recording of the Companys Earnings Call held with Investors/Analysts on November 20 2025 to discuss the financial performance of the Company for the half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Postponement Of Analyst / Institutional Investor Earnings Call Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "17-Nov-2025",
      "details": "Intimation regarding postponement of Analyst/ Institutional Investor Earnings Call due to unforeseen work exigencies.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Prevest Denpro Ltd has declared <strong>10%</strong> dividend, ex-date: 03 Sep 25",
          "dt": "2025-09-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Is Prevest Denpro overvalued or undervalued?

2025-12-04 08:45:51

Valuation Metrics and Financial Health

Prevest Denpro’s price-to-earnings (PE) ratio stands at approximately 27.3, which is elevated compared to many industry peers but not excessively high for a growth-oriented healthcare company. The price-to-book (P/B) ratio of 4.63 indicates that investors are paying a significant premium over the company’s net asset value, reflecting expectations of strong future earnings growth.

Enterprise value to EBITDA (EV/EBITDA) at 19.4 and EV to EBIT at 21.2 further suggest that the market values the company’s operating profits highly. These multiples are lower than some very expensive peers but still indicate a premium valuation.

Importantly, Prevest Denpro’s return on capital employed (ROCE) is an impressive 52.16%, signalling high...

Read More

Why is Prevest Denpro falling/rising?

2025-11-25 01:44:05

Recent Price Movement and Market Context

Prevest Denpro’s stock has been on a downward spiral, losing 8.48% over the past week compared to a near-flat Sensex performance of -0.06%. The one-month decline is even more pronounced at -18.68%, while the Sensex has gained 0.82% in the same period. Year-to-date, the stock has fallen 27.14%, starkly contrasting with the Sensex’s 8.65% rise. Over the last year, Prevest Denpro has delivered a negative return of 20.39%, whereas the benchmark index has appreciated by 7.31%. Even over a three-year horizon, the stock’s 9.85% gain pales in comparison to the Sensex’s robust 36.34% advance.

On 24-Nov, the stock opened with a gap down of 2.21% and continued to weaken, hitting an intraday low of ₹429.90, marking a 6.58% drop on the day. ...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

24-Nov-2025 | Source : BSE

Transcipt of the Companys Earning call held on November 20 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

21-Nov-2025 | Source : BSE

Please find enclosed the audio recording of the Companys Earnings Call held with Investors/Analysts on November 20 2025 to discuss the financial performance of the Company for the half year ended September 30 2025

Intimation Regarding Postponement Of Analyst / Institutional Investor Earnings Call Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

17-Nov-2025 | Source : BSE

Intimation regarding postponement of Analyst/ Institutional Investor Earnings Call due to unforeseen work exigencies.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Prevest Denpro Ltd has declared 10% dividend, ex-date: 03 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available